ProCredit Holding Valuation
Is PCZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
6/6Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PCZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PCZ (€7.84) is trading below our estimate of fair value (€23.08)
Significantly Below Fair Value: PCZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PCZ?
Key metric: As PCZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is PCZ's PE Ratio? | |
|---|---|
| PE Ratio | 4.3x |
| Earnings | €106.91m |
| Market Cap | €465.30m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 0.4x |
Price to Earnings Ratio vs Peers
How does PCZ's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 7.4x | ||
MBK Merkur PrivatBank KgaA | 10x | 8.6% | €107.3m |
CBK Commerzbank | 8.7x | 8.8% | €18.7b |
NBP National Bank of Pakistan | 7.4x | 41.3% | PK₨128.3b |
BAVL Raiffeisen Bank JSC | 3.5x | n/a | ₴20.9b |
PCZ ProCredit Holding | 4.3x | 9.9% | €465.3m |
Price-To-Earnings vs Peers: PCZ is good value based on its Price-To-Earnings Ratio (4.3x) compared to the peer average (7.4x).
Price to Earnings Ratio vs Industry
How does PCZ's PE Ratio compare vs other companies in the European Banks Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: PCZ is good value based on its Price-To-Earnings Ratio (4.3x) compared to the European Banks industry average (7.3x).
Price to Earnings Ratio vs Fair Ratio
What is PCZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 4.3x |
| Fair PE Ratio | 9.3x |
Price-To-Earnings vs Fair Ratio: PCZ is good value based on its Price-To-Earnings Ratio (4.3x) compared to the estimated Fair Price-To-Earnings Ratio (9.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €7.84 | €16.88 +115.3% | 9.3% | €19.00 | €15.25 | n/a | 3 |
| Nov ’25 | €8.24 | €17.22 +108.9% | 11.8% | €20.00 | €15.25 | n/a | 3 |
| Oct ’25 | €8.68 | €17.22 +98.3% | 11.8% | €20.00 | €15.25 | n/a | 3 |
| Sep ’25 | €8.56 | €17.22 +101.1% | 11.8% | €20.00 | €15.25 | n/a | 3 |
| Aug ’25 | €8.66 | €17.43 +101.3% | 13.5% | €20.00 | €14.30 | n/a | 3 |
| Jul ’25 | €9.28 | €17.43 +87.9% | 13.5% | €20.00 | €14.30 | n/a | 3 |
| Jun ’25 | €9.84 | €17.43 +77.2% | 13.5% | €20.00 | €14.30 | n/a | 3 |
| May ’25 | €9.56 | €17.57 +83.8% | 12.4% | €20.00 | €14.70 | n/a | 3 |
| Apr ’25 | €9.14 | €17.00 +86.0% | 17.3% | €20.00 | €13.00 | n/a | 3 |
| Mar ’25 | €7.74 | €15.00 +93.8% | 9.4% | €16.00 | €13.00 | n/a | 3 |
| Feb ’25 | €7.90 | €15.00 +89.9% | 9.4% | €16.00 | €13.00 | n/a | 3 |
| Jan ’25 | €8.10 | €15.00 +85.2% | 9.4% | €16.00 | €13.00 | n/a | 3 |
| Dec ’24 | €8.36 | €15.00 +79.4% | 9.4% | €16.00 | €13.00 | n/a | 3 |
| Nov ’24 | €7.00 | €13.47 +92.4% | 11.3% | €15.00 | €11.40 | €8.24 | 3 |
| Oct ’24 | €6.80 | €13.47 +98.0% | 11.3% | €15.00 | €11.40 | €8.68 | 3 |
| Sep ’24 | €7.14 | €13.47 +88.6% | 11.3% | €15.00 | €11.40 | €8.56 | 3 |
| Aug ’24 | €7.28 | €13.50 +85.4% | 11.1% | €15.00 | €12.00 | €8.66 | 2 |
| Jul ’24 | €7.52 | €13.50 +79.5% | 11.1% | €15.00 | €12.00 | €9.28 | 2 |
| Jun ’24 | €6.70 | €13.00 +94.0% | 7.7% | €14.00 | €12.00 | €9.84 | 2 |
| May ’24 | €6.28 | €12.00 +91.1% | 16.7% | €14.00 | €10.00 | €9.56 | 2 |
| Apr ’24 | €6.06 | €12.00 +98.0% | 16.7% | €14.00 | €10.00 | €9.14 | 2 |
| Mar ’24 | €5.18 | €9.75 +88.2% | 17.9% | €11.50 | €8.00 | €7.74 | 2 |
| Feb ’24 | €5.20 | €9.75 +87.5% | 17.9% | €11.50 | €8.00 | €7.90 | 2 |
| Jan ’24 | €3.73 | €9.46 +153.6% | 15.7% | €11.50 | €8.00 | €8.10 | 3 |
| Dec ’23 | €3.76 | €9.46 +151.6% | 15.7% | €11.50 | €8.00 | €8.36 | 3 |
| Nov ’23 | €3.39 | €9.13 +169.2% | 11.3% | €10.50 | €8.00 | €7.00 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Crédit Agricole
€40.3b
Provides retail, corporate, insurance, and investment banking products and services in France and internationally.
XCA
€13.40
7D
2.8%
1Y
14.3%
Eurobank Ergasias Services and Holdings
€7.3b
Provides retail banking, corporate and private banking, asset management, treasury, capital market, and other services primarily in Greece, rest of Europe, and internationally.
EFGD
€1.98
7D
-0.08%
1Y
21.5%
Alior Bank
zł11.4b
Provides banking products and services for individuals, businesses, and enterprises in Poland.
A6O
zł19.54
7D
-9.2%
1Y
13.6%